The DOI matches its Crossref record; 389 of the 389 references it cites were found in a registry or an index.
Post‐translational modifications of histones: Mechanisms, biological functions, and therapeutic targets
Open accessAbstract
Histones are DNA‐binding basic proteins found in chromosomes. After the histone translation, its amino tail undergoes various modifications, such as methylation, acetylation, phosphorylation, ubiquitination, malonylation, propionylation, butyrylation, crotonylation, and lactylation, which together constitute the “histone code.” The relationship between their combination and biological function can be used as an important epigenetic marker. Methylation and demethylation of the same histone residue, acetylation and deacetylation, phosphorylation and dephosphorylation, and even methylation and acetylation between different histone residues cooperate or antagonize with each other, forming a complex network. Histone‐modifying enzymes, which cause numerous histone codes, have become a hot topic in the research on cancer therapeutic targets. Therefore, a thorough understanding of the role of histone post‐translational modifications (PTMs) in cell life activities is very important for preventing and treating human diseases. In this review, several most thoroughly studied and newly discovered histone PTMs are introduced. Furthermore, we focus on the histone‐modifying enzymes with carcinogenic potential, their abnormal modification sites in various tumors, and multiple essential molecular regulation mechanism. Finally, we summarize the missing areas of the current research and point out the direction of future research. We hope to provide a comprehensive understanding and promote further research in this field.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–389 of 389
HBO1 is a versatile histone acyltransferase critical for promoter histone acylations
Xiao, Y., Li, W., Yang, H., Pan, L., Zhang, L., Lu, L., Chen, J., Wei, W., Ye, J., Li, J., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab607 · Cited by 97
Bauer, T. M., Besse, B., Martínez‐Martí, A., Trigo, J. M., Moreno, V., Garrido, P., Ferron‐Brady, G., Wu, Y., Park, J., Collingwood, T. S., et al. (2019) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2019.06.021 · Cited by 96
Spyropoulou, A., Gargalionis, A. N., Dalagiorgou, G., Adamopoulos, C., Papavassiliou, K. A., Lea, R. W., Piperi, C., & Papavassiliou, A. G. (2013) · NeuroMolecular Medicine · doi:10.1007/s12017-013-8254-x · Cited by 95
GSKJ4, an H3K27me3 demethylase inhibitor, effectively suppresses the breast cancer stem cells
Yan, N., Xu, L., Wu, X., Zhang, L., Fei, X., Cao, Y., & Zhang, F. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.08.024 · Cited by 95
Ovarian cancer: epigenetics, drug resistance, and progression
Xie, W., Sun, H., Li, X., Lin, F., Wang, Z., & Wang, X. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02136-y · Cited by 95
Bao, L., Diao, H., Dong, N., Su, X., Wang, B., Mo, Q., Yu, H., Wang, X., & Chen, C. (2016) · Cell Biology and Toxicology · doi:10.1007/s10565-016-9347-8 · Cited by 93
Mitchell, L. H., Boriack-Sjodin, P. A., Smith, S., Thomenius, M., Rioux, N., Munchhof, M., Mills, J. E., Klaus, C., Totman, J., Riera, T. V., et al. (2016) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5b00272 · Cited by 91
Chromatin Hyperacetylation Impacts Chromosome Folding by Forming a Nuclear Subcompartment
Rosencrance, C. D., Ammouri, H., Yu, Q., Ge, T., Rendleman, E. J., Marshall, S. A., & Eagen, K. P. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.03.018 · Cited by 91
Extracellular and nuclear PD-L1 in modulating cancer immunotherapy
Xiong, W., Gao, Y., Wei, W., & Zhang, J. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.03.003 · Cited by 91
Raman Spectroscopy: A Novel Technology for Gastric Cancer Diagnosis
Liu, K., Zhao, Q., Li, B., & Zhao, X. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.856591 · Cited by 91
Shigeyasu, K., Toden, S., Ozawa, T., Matsuyama, T., Nagasaka, T., Ishikawa, T., Sahoo, D., Ghosh, P., Uetake, H., Fujiwara, T., et al. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01277-4 · Cited by 90
Pontiki, E. A., & Hadjipavlou‐Litina, D. (2010) · Medicinal Research Reviews · doi:10.1002/med.20200 · Cited by 89
The emerging roles of HDACs and their therapeutic implications in cancer
Hai, R., Yang, D., Zheng, F., Wang, W., Han, X., Bode, A. M., & Luo, X. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175216 · Cited by 89
The Role of Histone Tails in the Nucleosome: A Computational Study
Erler, J., Zhang, R., Petridis, L., Cheng, X., Smith, J. C., & Langowski, J. (2014) · Biophysical Journal · doi:10.1016/j.bpj.2014.10.065 · Cited by 88
Biological function and histone recognition of family IV bromodomain‐containing proteins
Lloyd, J. T., & Glass, K. C. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26010 · Cited by 88
Targeting LSD1 for acute myeloid leukemia (AML) treatment
Zhang, S., Liu, M., Yao, Y., Yu, B., & Liu, H. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105335 · Cited by 88
Histone H3 phosphorylation: Universal code or lineage specific dialects?
Cerutti, H. D., & Casas-Mollano, J. A. (2009) · Epigenetics · doi:10.4161/epi.4.2.7781 · Cited by 86
Bmi1 is essential for leukemic reprogramming of myeloid progenitor cells
Yuan, J., Takeuchi, M., Negishi, M., Oguro, H., Ichikawa, H., & Iwama, A. (2011) · Leukemia · doi:10.1038/leu.2011.85 · Cited by 86
The Emerging Role of H3K9me3 as a Potential Therapeutic Target in Acute Myeloid Leukemia
Monaghan, L., Massett, M. E., Bunschoten, R. P., Hoose, A., Pirvan, P.-A., Liskamp, R. M. J., Jørgensen, H. G., & Huang, X. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00705 · Cited by 86
Chiral Posttranslational Modification to Lysine ε-Amino Groups
Moreno-Yruela, C., Bæk, M., Monda, F., & Olsen, C. A. (2022) · Accounts of Chemical Research · doi:10.1021/acs.accounts.2c00115 · Cited by 85
Histone H2A ubiquitination in transcriptional regulation and DNA damage repair
Zhou, W., Wang, X., & Rosenfeld, M. G. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.09.016 · Cited by 84
Wang, D., Han, S., Peng, R., Jiao, C., Wang, X., Yang, X., Yang, R., & Li, X. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0311-5 · Cited by 84
Zheng, Y., Wang, Z., Wei, S., Liu, Z., & Chen, G. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.11.034 · Cited by 84
The histone acetyltransferase HBO1 functions as a novel oncogenic gene in osteosarcoma
Gao, Y.-Y., Ling, Z., Zhu, Y.-R., Shi, C., Wang, Y., Zhang, X.-Y., Zhang, Z.-Q., Jiang, Q. L., Chen, M., Yang, S., et al. (2021) · Theranostics · doi:10.7150/thno.55655 · Cited by 84
The Human Histone Acetyltransferase P/CAF is a Promiscuous Histone Propionyltransferase
Leemhuis, H., Packman, L. C., Nightingale, K. P., & Hollfelder, F. (2008) · ChemBioChem · doi:10.1002/cbic.200700556 · Cited by 80
Keniry, A., Gearing, L. J., Jansz, N., Liu, J. J., Holik, A. Z., Hickey, P. F., Kinkel, S., Moore, D., Breslin, K. A., Chen, K., et al. (2016) · Epigenetics & Chromatin · doi:10.1186/s13072-016-0064-6 · Cited by 79
Self-citationH3K18Ac as a Marker of Cancer Progression and Potential Target of Anti-Cancer Therapy
Hałasa, M., Wawruszak, A., Przybyszewska-Podstawka, A., Jaruga, A., Guz, M., Kałafut, J., Stepulak, A., & Cybulski, M. (2019) · Cells · doi:10.3390/cells8050485 · Cited by 79
Current paradigms in epigenetic anticancer therapeutics and future challenges
Singh, M. P., Kumar, V., Sehrawat, N., Yadav, M. K., Chaudhary, M., Upadhyay, S. K., Kumar, S., Sharma, V., Kumar, S., Dilbaghi, N., et al. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.03.013 · Cited by 79
Biomolecular condensates: Formation mechanisms, biological functions, and therapeutic targets
Niu, X., Zhang, L., Wu, Y., Zong, Z., Wang, B., Liu, J., Zhang, L., & Zhou, F. (2023) · MedComm · doi:10.1002/mco2.223 · Cited by 78
Smyd3-associated regulatory pathways in cancer
Giakountis, A., Moulos, P., Sarris, M. E., Hatzis, P., & Talianidis, I. (2016) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2016.08.008 · Cited by 76
Kuo, K.-T., Huang, W.-C., Bamodu, O. A., Lee, W., Wang, C., Hsiao, M., Wang, L.-S., & Yeh, C. (2018) · Clinical Epigenetics · doi:10.1186/s13148-018-0533-9 · Cited by 76
Liu, S., Li, B., Xu, J., Hu, S., Zhan, N., Wang, H., Gao, C., Li, J., & Xu, X. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00213 · Cited by 76
Kari, V., Raul, S. K., Henck, J. M., Kitz, J., Krämer, F., Kosinsky, R. L., Übelmesser, N., Mansour, W. Y., Eggert, J., Spitzner, M., et al. (2019) · Clinical Epigenetics · doi:10.1186/s13148-018-0601-1 · Cited by 75
So, C. C., Ramachandran, S., & Martín, A. (2019) · Molecular and Cellular Biology · doi:10.1128/mcb.00488-18 · Cited by 75
Histone crotonylation-centric gene regulation
Li, K., & Wang, Z. (2021) · Epigenetics & Chromatin · doi:10.1186/s13072-021-00385-9 · Cited by 75
Codependency of H2B monoubiquitination and nucleosome reassembly on Chd1Preprint
Lee, J., Garrett, A. S., Yen, K., Takahashi, Y.-H., Hu, D., Jackson, J., Seidel, C. W., Pugh, B. F., & Shilatifard, A. (2012) · Genes & Development · doi:10.1101/gad.186841.112 · Cited by 74
Role of the polycomb group gene BMI1 in normal and leukemic hematopoietic stem and progenitor cells
Schuringa, J. J., & Vellenga, E. (2010) · Current Opinion in Hematology · doi:10.1097/moh.0b013e328338c439 · Cited by 74
Synthetic post-translational modification of histones
Nadal, S., Raj, R., Mohammed, S., & Davis, B. G. (2018) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2018.02.004 · Cited by 74
Histone Deacetylase (HDAC) 1 and 2 Expression and Chemotherapy in Gastric Cancer
Mutze, K., Langer, R., Becker, K., Ott, K., Novotny, A., Luber, B., Hapfelmeier, A., Göttlicher, M., Höfler, H., & Keller, G. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-1182-1 · Cited by 73
Wu, X., Li, R., Song, Q., Zhang, C., Jia, R., Han, Z., Zhou, L., Sui, H. X., Liu, X., Zhu, H., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1439-x · Cited by 72
An in vitro investigation of metabolically sensitive biomarkers in breast cancer progression
Simpson, N. E., Tryndyak, V., Beland, F. A., & Pogribny, I. P. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1871-x · Cited by 71
Histone H3 acetylation is associated with reduced p21WAF1/CIP1 expression by gastric carcinoma
Mitani, Y., Oue, N., Hamai, Y., Aung, P. P., Matsumura, S., Nakayama, H., Kamata, N., & Yasui, W. (2004) · The Journal of Pathology · doi:10.1002/path.1684 · Cited by 71
PRMT1 enhances oncogenic arginine methylation of NONO in colorectal cancer
Yin, X.-K., Wang, Y., Wang, F., Feng, W.-X., Bai, S.-M., Zhao, W.-W., Feng, L.-L., Wei, M., Qin, C.-L., Wang, F., et al. (2021) · Oncogene · doi:10.1038/s41388-020-01617-0 · Cited by 71
Conjugation and deconjugation of ubiquitin regulating the destiny of proteins
Baek, K. (2003) · Experimental & Molecular Medicine · doi:10.1038/emm.2003.1 · Cited by 67
Structural basis for acyl-group discrimination by human Gcn5L2
Ringel, A. E., & Wolberger, C. (2016) · Acta Crystallographica Section D Structural Biology · doi:10.1107/s2059798316007907 · Cited by 67
Dynamic assembly and activation of estrogen receptor α enhancers through coregulator switchingPreprint
Murakami, S., Nagari, A., & Kraus, W. L. (2017) · Genes & Development · doi:10.1101/gad.302182.117 · Cited by 67
Peng, K., Su, G., Ji, J., Yang, X., Miao, M., Mo, P., Li, M., Xu, J., Li, W., & Yu, C. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.001730 · Cited by 67
Zhao, J., Jin, W., Yi, K., Wang, Q., Zhou, J., Tan, Y., Xu, C., Xiao, M., Hong, B., Xu, F., et al. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105764 · Cited by 67
Tang, Y.-A., Wen, W.-L., Chang, J.-W., Wei, T.-T., Tan, Y. C., Salunke, S. B., Chen, C., Chen, C., & Wang, Y. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012417 · Cited by 66
SMYD3-Mediated H2A.Z.1 Methylation Promotes Cell Cycle and Cancer Proliferation
Tsai, C.-H., Chen, Y., Yu, C., Tzeng, S., Wu, I.-C., Kuo, W., Lin, M.-C., Chan, N., Wu, K., & Teng, S. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0500 · Cited by 66
PCGF5 is required for neural differentiation of embryonic stem cells
Yao, M., Zhou, X., Zhou, J., Gong, S., Hu, G., Li, J., Huang, K., Lai, P., Shi, G. W., Hutchins, A. P., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03781-0 · Cited by 66
Sarcopenia in hepatocellular carcinoma: Current knowledge and future directions
Perisetti, A., Goyal, H., Yendala, R., Chandan, S., Tharian, B., & Thandassery, R. B. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i4.432 · Cited by 66
Chen, K.-L., Zhang, F., Ding, J., Liang, Y., Zhan, Z., Zhan, Y., Chen, L., & Ding, Y. (2017) · Journal of Cancer · doi:10.7150/jca.20482 · Cited by 65
Jeusset, L. M., & McManus, K. J. (2017) · Cancers · doi:10.3390/cancers9120167 · Cited by 65
Proteomics of post-translational modifications in colorectal cancer: Discovery of new biomarkers
Zhu, G., Jin, L., Sun, W., Wang, S., & Liu, N. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188735 · Cited by 65
Wang, Z., Tang, F., Qi, G., Yuan, S., Zhang, G., Tang, B., & He, S. (2015) · Europe PMC (PubMed Central) · Cited by 64
Structure-Based Design of a Novel SMYD3 Inhibitor that Bridges the SAM-and MEKK2-Binding Pockets
Aller, G. S. V., Graves, A. P., Elkins, P. A., Bonnette, W. G., McDevitt, P. J., Zappacosta, F., Annan, R. S., Dean, T. W., Su, D., Carpenter, C. L., et al. (2016) · Structure · doi:10.1016/j.str.2016.03.010 · Cited by 63
Jiang, Y., Lyu, T., Che, X., Jia, N., Li, Q., & Feng, W. (2019) · Journal of Cancer · doi:10.7150/jca.29861 · Cited by 63
SETDB1 promotes the progression of colorectal cancer via epigenetically silencing p21 expression
Cao, N., Yu, Y., Zhu, H., Chen, M., Chen, P., Zhuo, M., Mao, Y., Li, L., Zhao, Q., Wu, M., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2561-6 · Cited by 63
Intracellular Crotonyl-CoA Stimulates Transcription through p300-Catalyzed Histone Crotonylation
Sabari, B. R., Tang, Z., Huang, H., Yong‐Gonzalez, V., Molina, H., Kong, H. E., Dai, L., Shimada, M., Cross, J. R., Zhao, Y., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.01.013 · Cited by 63
The functional and mechanistic relatedness of EZH2 and menin in hepatocellular carcinoma
Gao, S.-B., Xu, B., Ding, L., Zheng, Q., Zhang, L., Zheng, Q., Li, S.-H., Feng, Z.-J., Wei, J., Yin, Z., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.05.015 · Cited by 62
Self-citationChen, X., Song, N., Matsumoto, K., Nanashima, A., Nagayasu, T., Hayashi, T., Ying, M., Endo, D., Wu, Z., & Koji, T. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.2062 · Cited by 62
Tarcic, O., Granit, R. Z., Pateras, I. S., Masury, H., Maly, B., Zwang, Y., Yarden, Y., Gorgoulis, V. G., Pikarsky, E., Ben‐Porath, I., et al. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2016.126 · Cited by 62
Wang, Z., Zhu, L., Guo, T., Wang, Y., & Yang, J. (2015) · Human Pathology · doi:10.1016/j.humpath.2015.04.001 · Cited by 60
Taniue, K., Hayashi, T., Kamoshida, Y., Kurimoto, A., Takeda, Y., Negishi, L., Iwasaki, K., Kawamura, Y., Goshima, N., & Akiyama, T. (2019) · Oncogene · doi:10.1038/s41388-019-1032-y · Cited by 60
Hbo1 Is a Cyclin E/CDK2 Substrate That Enriches Breast Cancer Stem-like Cells
Duong, M. T., Akli, S., Macalou, S., Biernacka, A., Debeb, B. G., Yi, M., Hunt, K. K., & Keyomarsi, K. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0013 · Cited by 59
Lan, R., & Wang, Q. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03296-x · Cited by 59
Structure‐Guided Discovery of a Potent and Selective Cell‐Active Inhibitor of SETDB1 Tudor Domain
Guo, Y., Mao, X., Xiong, L., Xia, A., You, J., Lin, G., Wu, C., Huang, L., Wang, Y., & Yang, S. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202017200 · Cited by 58
Histone Monoubiquitination in Chromatin Remodelling: Focus on the Histone H2B Interactome and Cancer
Marsh, D. J., Ma, Y., & Dickson, K.-A. (2020) · Cancers · doi:10.3390/cancers12113462 · Cited by 57
Plasma cfDNA methylation markers for the detection and prognosis of ovarian cancer
Liang, L., Zhang, Y., Li, C., Liao, Y., Wang, G.-Q., Xu, J., Li, Y., Yuan, G., Sun, Y.-C., Zhang, R., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104222 · Cited by 57
Global crotonylome reveals hypoxia-mediated lamin A crotonylation regulated by HDAC6 in liver cancer
Zhang, D., Tang, J. P., Xu, Y., Huang, X., Wang, Y., Jin, X., Wu, G., & Liu, P. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05165-1 · Cited by 57
Self-citationDu, Z., Liu, X., Chen, T., Gao, W., Wu, Z., Hu, Z., Wei, D., Gao, C., & Li, Q. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.02.037 · Cited by 56
DNA methylation as a pathogenic event and as a therapeutic target in AML
Schoofs, T., & Müller‐Tidow, C. (2011) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2011.04.013 · Cited by 56
Benard, A., Goossens-Beumer, I. J., van Hoesel, A. Q., Horati, H., de Graaf, W., Putter, H., Zeestraten, E. C. M., Liefers, G., van de Velde, C. J. �., & Kuppen, P. J. K. (2014) · Histopathology · doi:10.1111/his.12534 · Cited by 56
HBO1 promotes cell proliferation in bladder cancer via activation of Wnt/β‐catenin signaling
Chen, Z., Zhou, L., Wang, L., Kazobinka, G., Zhang, X., Han, X., Li, B., & Hou, T. (2017) · Molecular Carcinogenesis · doi:10.1002/mc.22715 · Cited by 56
Ogawa, S., Fukuda, A., Matsumoto, Y., Hanyu, Y., Sono, M., Fukunaga, Y., Masuda, T., Araki, O., Nagao, M., Yoshikawa, T., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.04.047 · Cited by 56
Høgh, R. I., Møller, S. H., Jepsen, S. D., Mellergaard, M., Lund, A., Pejtersen, M., Fitzner, E., Andresen, L., & Skov, S. (2020) · The FASEB Journal · doi:10.1096/fj.202000162r · Cited by 56
Saha, N., & Muntean, A. G. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188498 · Cited by 56
Yin, C., Ke, X., Zhang, R., Hou, J., Dong, Z., Wang, F., Zhang, K., Zhong, X. Z., Yang, L., & Cui, H. (2019) · The FASEB Journal · doi:10.1096/fj.201900233rr · Cited by 54
Epigenetic Biomarkers for the Diagnosis and Treatment of Liver Disease
Arechederra, M., Recalde, M., Gárate‐Rascón, M., Fernández‐Barrena, M. G., Avila, M. A., & Berasain, C. (2021) · Cancers · doi:10.3390/cancers13061265 · Cited by 54
Jimeno, A., Rubio‐Viqueira, B., Rajeshkumar, N. V., Chan, A., Solomon, A., & Hidalgo, M. M. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0693 · Cited by 53
KAT7 is a genetic vulnerability of acute myeloid leukemias driven by MLL rearrangements
Au, Y. Z., Gu, M., Braekeleer, E. D., Gozdecka, M., Aspris, D., Tarumoto, Y., Cooper, J. L., Yu, J., Ong, S. H., Chen, X. X., et al. (2020) · Leukemia · doi:10.1038/s41375-020-1001-z · Cited by 53
Altered global histone-trimethylation code and H3F3A-ATRX mutation in pediatric GBM
Pathak, P., Jha, P., Purkait, S., Sharma, V., Suri, V. S., Sharma, M. C., Faruq, M., Suri, A., & Sarkar, C. (2014) · Journal of Neuro-Oncology · doi:10.1007/s11060-014-1675-z · Cited by 52
Lysine demethylase 5B (KDM5B): A potential anti-cancer drug target
Zheng, Y., Chang, J., Wang, L.-C., Ren, H.-M., Pang, J., & Liu, H. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.10.040 · Cited by 52
Udugama, M., Vinod, B., Chan, F. L., Hii, L. L., Garvie, A., Collas, P., Kalitsis, P., Steer, D. L., Das, P. P., Tripathi, P., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac259 · Cited by 52
A kinase‐dependent role for Haspin in antagonizing Wapl and protecting mitotic centromere cohesion
Liang, C., Chen, Q., Yi, Q., Zhang, M., Yan, H., Zhang, B., Zhou, L., Zhang, Z., Qi, F., Ye, S., et al. (2017) · EMBO Reports · doi:10.15252/embr.201744737 · Cited by 51
EZH2 is a potential prognostic predictor of glioma
Chen, Y., Hou, S., Jiang, R., Sun, J., Cheng, C., & Qian, Z. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16149 · Cited by 51
The Phosphorylated Form of the Histone H2AX (γH2AX) in the Brain from Embryonic Life to Old Age
Merighi, A., Gionchiglia, N., Granato, A., & Lossi, L. (2021) · Molecules · doi:10.3390/molecules26237198 · Cited by 51
Niu, J., Li, W., Liang, C., Wang, X., Yao, X., Yang, R., Zhang, Z., Liu, F., Liu, F., Pei, S., et al. (2020) · Science Signaling · doi:10.1126/scisignal.abb5727 · Cited by 50
Phosphorylation of Histone H2B Serine 32 Is Linked to Cell Transformation
Lau, A. T. Y., Lee, S., Xu, Y., Zheng, D., Cho, Y., Zhu, F., Kim, H. G., Li, S.-Q., Zhang, Z., Bode, A. M., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.215590 · Cited by 49
Self-citationKuang, Y., Lu, F., Guo, J., Xu, H., Wang, Q., Xu, C., Zeng, L.-J., & Yi, S. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s134784 · Cited by 49
H3K4me2 regulates the recovery of protein biosynthesis and homeostasis following DNA damage
Wang, S., Meyer, D. H., & Schumacher, B. (2020) · Nature Structural & Molecular Biology · doi:10.1038/s41594-020-00513-1 · Cited by 49
Lysine Acetylation/Deacetylation Modification of Immune-Related Molecules in Cancer Immunotherapy
Ding, P., Ma, Z., Liu, D., Pan, M., Li, H., Feng, Y., Zhang, Y., Shao, C., Jiang, M., Lu, D., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.865975 · Cited by 49
Histone Acetyl Transferase (HAT) HBO1 and JADE1 in Epithelial Cell Regeneration
Havasi, A., Haegele, J. A., Gall, J. M., Blackmon, S., Ichimura, T., Bonegio, R. G. B., & Panchenko, M. V. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.09.017 · Cited by 48
Food Insecurity and Rural Adolescent Personal Health, Home, and Academic Environments
Shanafelt, A., Hearst, M. O., Wang, Q., & Nanney, M. S. (2016) · Journal of School Health · doi:10.1111/josh.12397 · Cited by 48
Expression of H3K4me3 and H3K9ac in breast cancer
Berger, L., Kolben, T., Meister, S., Kolben, T. M., Schmoeckel, E., Mayr, D. C., Mahner, S., Jeschke, U., Ditsch, N. C., & Beyer, S. (2020) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-020-03265-z · Cited by 48
The c‐MYC–BMI1 axis is essential for SETDB1‐mediated breast tumourigenesis
Xiao, J., Sun, Q., Ding, L., Chien, W., Liu, X., Mayakonda, A., Jiang, Y., Loh, X.-Y., Ran, X., Doan, N., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5126 · Cited by 47
LSD1: Expanding Functions in Stem Cells and Differentiation
Martinez‐Gamero, C., Malla, S., & Aguiló, F. (2021) · Cells · doi:10.3390/cells10113252 · Cited by 47
Understanding the Contribution of Lactate Metabolism in Cancer Progress: A Perspective from Isomers
Cai, M., Wan, J., Cai, K., Song, H., Wang, Y., Sun, W., & Hu, J. (2022) · Cancers · doi:10.3390/cancers15010087 · Cited by 47
Targeting the USP7/RRM2 axis drives senescence and sensitizes melanoma cells to HDAC/LSD1 inhibitors
Granieri, L., Marocchi, F., Melixetian, M. B., Mohammadi, N., Nicoli, P., Cuomo, A., Bonaldi, T., Confalonieri, S., Pisati, F., Giardina, G., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111396 · Cited by 46
MICA/B antibody induces macrophage-mediated immunity against acute myeloid leukemia
da Silva, P. H. A., Xing, S., Kotini, A. G., Papapetrou, E. P., Song, X., Wucherpfennig, K. W., Mascarenhas, J. O., & de Andrade, L. F. (2021) · Blood · doi:10.1182/blood.2021011619 · Cited by 45
Wang, Y., Zhang, M., Song, W., Cai, Q., Zhang, L., Sun, X., Zou, L., Zhang, H., Wang, L., & Xue, H. (2022) · American Journal of Hematology · doi:10.1002/ajh.26499 · Cited by 44
Self-citationGutierrez, E., Cahatol, I., Bailey, C., Lafargue, A. M., Zhang, N., Song, Y., Tian, H., Zhang, Y., Chan, R., Gu, K., et al. (2019) · Cancers · doi:10.3390/cancers11060818 · Cited by 43
Self-citationChai, X., Guo, J., Dong, R., Yang, X., Deng, C., Wei, C., Xu, J., Han, W., Lu, J., Gao, C., et al. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.313 · Cited by 43
Self-citationLSD1-mediated epigenetic modification contributes to ovarian cancer cell migration and invasion
LI, Y., Wan, X., Ye, W., Liu, X., LAI, W., Zhang, L., Jin, J., Wu, C., Shao, Q., Shao, G., et al. (2016) · Oncology Reports · doi:10.3892/or.2016.4729 · Cited by 42
Elucidating the mechanism of action of domatinostat (4SC-202) in cutaneous T cell lymphoma cells
Wobser, M., Weber, A., Glunz, A., Tauch, S., Seitz, K., Butelmann, T., Hesbacher, S., Goebeler, M., Bartz, R., Kohlhof, H., et al. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0719-4 · Cited by 41
Peng, K., Zhuo, M., Li, M., Chen, Q., Mo, P., & Yu, C. (2020) · Oncogene · doi:10.1038/s41388-020-01483-w · Cited by 41
SAHA Regulates Histone Acetylation, Butyrylation, and Protein Expression in Neuroblastoma
Xu, G., Wang, J., Wu, Z., Qian, L., Dai, L., Wan, X., Tan, M., Zhao, Y., & Wu, Y. (2014) · Journal of Proteome Research · doi:10.1021/pr500497e · Cited by 40
Wu, Z., Liu, J., Zhang, Q.-D., Lv, D., Wu, N.-F., & Zhou, J. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx101 · Cited by 40
Yang, Z., He, M., Austin, J., Pfleger, J. M., & Abdellatif, M. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101249 · Cited by 40
The histone acetyltransferase hMOF promotes vascular invasion in hepatocellular carcinoma
Poté, N., Cros, J. F., Laouirem, S., Raffenne, J., Negrão, M., Albuquerque, M., Bédossa, P., Ferreira, M. G., Ait‐Si‐Ali, S., Fior, R., et al. (2020) · Liver International · doi:10.1111/liv.14381 · Cited by 39
Zinc-dependent histone deacetylases: Potential therapeutic targets for arterial hypertension
Kee, H. J., Kim, I., & Jeong, M. H. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115111 · Cited by 39
p53 Down-regulates SETDB1 gene expression during paclitaxel induced-cell death
Noh, H.-J., Kim, K.-A., & Kim, K. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.02.053 · Cited by 38
H4K12 and H3K18 Acetylation Associates With Poor Prognosis in Pancreatic Cancer
Juliano, C., Izetti, P., Pereira, M. P., dos Santos, A. P., Bravosi, C. P., Abujamra, A. L., Ashton‐Prolla, P., Osvaldt, A. B., & Edelweiss, M. I. A. (2015) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000194 · Cited by 38
Wu, J., Li, L., Jiang, G., Zhan, H., Zhu, X., & Yang, W. (2020) · Cell and Tissue Research · doi:10.1007/s00441-020-03281-y · Cited by 38
Self-citationAzzoni, V., Wicinski, J., Macario, M., Castagné, M., Finetti, P., Ambrosova, K., Rouault, C. D., Sergé, A., Farina, A., Agavnian, E., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04538-w · Cited by 38
Andresen, L. O., Hansen, K. A., Jensen, H., Pedersen, S. F., Stougaard, P., Hansen, H. R., Jurlander, J., & Skov, S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803014 · Cited by 37
miR-194 inhibits gastric cancer cell proliferation and tumorigenesis by targeting KDM5B.
Bao, J., Jh, Z., Li, C., & Gq, Z. (2016) · PubMed · Cited by 37
SETDB1 promotes gastric carcinogenesis and metastasis via upregulation of CCND1 and MMP9 expression
Shang, W., Wang, Y., Liang, X., Li, T., Shao, W., Liu, F., Cui, X., Wang, Y., Lv, L., Chai, L., et al. (2020) · The Journal of Pathology · doi:10.1002/path.5568 · Cited by 37
Self-citationGenomic profiling and prognostic factors of H3 K27M ‐mutant spinal cord diffuse glioma
Chai, R., Yan, H., An, S., Pang, B., Chen, H., Mu, Q., Zhang, K., Zhang, Y.-W., Liu, Y., Liu, X., et al. (2023) · Brain Pathology · doi:10.1111/bpa.13153 · Cited by 37
Quintela, M., Sieglaff, D. H., Gazze, A. S., Zhang, A., González, D., Francis, L. W., Webb, P., & Conlan, R. S. (2019) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2019.01.017 · Cited by 36
SETDB1 interactions with PELP1 contributes to breast cancer endocrine therapy resistance
Liu, Z., Liu, J., Ebrahimi, B., Pratap, U. P., He, Y., Altwegg, K. A., Tang, W., Li, X., Lai, Z., Chen, Y., et al. (2022) · Breast Cancer Research · doi:10.1186/s13058-022-01520-4 · Cited by 36
Prognostic value of ERCC1, RRM1, BRCA1 and SETDB1 in early stage of non-small cell lung cancer
Lafuente-Sanchis, A., Zúñiga, Á., Galbis, J. M., Cremades, A., Estors, M., Hernández, N. J. M., & Carretero, J. (2015) · Clinical & Translational Oncology · doi:10.1007/s12094-015-1440-6 · Cited by 35
Xiao, X., Liu, C., Pei, Y., Wang, Y., Kong, J., Lu, K., Ma, L., Dou, S., Wang, P., Li, G., et al. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.9b12448 · Cited by 35
Regulation of epithelial-mesenchymal transition by protein lysine acetylation
Kong, F., Ma, L., Wang, X., You, H., Zheng, K., & Tang, R. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00870-y · Cited by 35
Iizuka, M., Susa, T., Takahashi, Y., Tamamori‐Adachi, M., Kajitani, T., Okinaga, H., Fukusato, T., & Okazaki, T. (2013) · Cancer Science · doi:10.1111/cas.12303 · Cited by 34
Tao, Y., Zhong, C., Zhu, J., Xu, S., & Ding, J. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx142 · Cited by 34
Quantifying Tip60 (Kat5) stratifies breast cancer
McGuire, A., Casey, M., Shalaby, A., Kalinina, O., Curran, C. E., Webber, M., Callagy, G. M., Holian, E., Bourke, E., Kerin, M. J., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-40221-5 · Cited by 34
Hormone replacement therapy after breast cancer: Yes, No or maybe?
Ugras, S. K., & Rahman, R. L. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111180 · Cited by 34
Chemical Catalysis Intervening to Histone Epigenetics
Nozaki, T., & Kanai, M. (2021) · Accounts of Chemical Research · doi:10.1021/acs.accounts.1c00144 · Cited by 34
Massett, M. E., Monaghan, L., Patterson, S. D., Mannion, N., Bunschoten, R. P., Hoose, A., Marmiroli, S., Liskamp, R. M. J., Jørgensen, H. G., Vetrie, D. L. P., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03738-0 · Cited by 34
Taylor‐Papadimitriou, J., & Burchell, J. (2022) · Cells · doi:10.3390/cells11071113 · Cited by 34
Phosphorylation of Histone H4T80 Triggers DNA Damage Checkpoint Recovery
Millán-Zambrano, G., Santos-Rosa, H., Puddu, F., Robson, S. C., Jackson, S. P., & Kouzarides, T. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.09.023 · Cited by 33
Wang, X., Liang, C., Yao, X., Yang, R., Zhang, Z., Liu, F., Li, W., Pei, S., Ma, J., Xie, S., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.577108 · Cited by 33
Cruz‐Tapias, P., Zakharova, V., Pérez-Fernández, O. M., Mantilla, W. A., Ramírez-Clavijo, S. R., & Ait‐Si‐Ali, S. (2019) · Cancers · doi:10.3390/cancers11081134 · Cited by 32
Chemical biology and pharmacology of histone lysine methylation inhibitors
Barghout, S. H., Machado, R. A. C., & Baršytė-Lovejoy, D. (2022) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2022.194840 · Cited by 32
Balakin, K. V., Ivanenkov, Y. A., Kiselyov, A. S., & Tkachenko, S. E. (2007) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152007781668698 · Cited by 31
Silver Nanoparticle-Induced Phosphorylation of Histone H3 at Serine 10 Involves MAPK Pathways
Zhao, X., Rao, Y., Liang, J., Lin, S., Wang, X., Li, Z., & Huang, J. (2019) · Biomolecules · doi:10.3390/biom9020078 · Cited by 31
Gradl, S., Steuber, H., Weiske, J., Szewczyk, M., Schmees, N., Siegel, S., Stoeckigt, D., Christ, C. D., Li, F., Organ, S. L., et al. (2021) · SLAS DISCOVERY · doi:10.1177/24725552211019409 · Cited by 31
H3K4 demethylase KDM5B regulates cancer cell identity and epigenetic plasticity
He, R., Xhabija, B., Gopi, L. K., Kurup, J. T., Xu, Z., Liu, Z., & Kidder, B. L. (2022) · Oncogene · doi:10.1038/s41388-022-02311-z · Cited by 31
The Emerging Roles and Therapeutic Implications of Epigenetic Modifications in Ovarian Cancer
Wang, Y., Huang, Z., Li, B., Liu, L., & Huang, C. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.863541 · Cited by 31
Update of research on the role of EZH2 in cancer progression
Shen, L., Cui, Liang, L., Pang, & Liu (2013) · OncoTargets and Therapy · doi:10.2147/ott.s42453 · Cited by 30
Personalized Medicine for Primary Treatment of Serous Ovarian Cancer
Longo, D. L. (2019) · New England Journal of Medicine · doi:10.1056/nejme1914488 · Cited by 30
Identification of potential biomarkers and candidate small molecule drugs in glioblastoma
Lu, W., Xie, H., Yuan, C., Li, J.-J., Li, Z., & Wu, A. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01515-1 · Cited by 30
HBO1 overexpression is important for hepatocellular carcinoma cell growth
Zhong, W., Liu, H., Deng, L., Chen, G., & Liu, Y. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03818-1 · Cited by 30
Hayashi, Y., Harada, Y., Kagiyama, Y., Nishikawa, S., Ding, Y., Imagawa, J., Shingai, N., Kato, N., Kitaura, J., Hokaiwado, S., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2018025007 · Cited by 29
The transcription factor code: a beacon for histone methyltransferase docking
Garcia, G. T., & Graf, T. (2021) · Trends in Cell Biology · doi:10.1016/j.tcb.2021.04.001 · Cited by 29
Histone H3 Serine 28 Is Essential for Efficient Polycomb-Mediated Gene Repression in Drosophila
Yung, P. Y. K., Stützer, A., Fischle, W., Martinez, A., & Cavalli, G. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.04.055 · Cited by 28
Decreased histone H2B monoubiquitination in malignant gastric carcinoma
Wang, Z. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i44.8099 · Cited by 28
LSD1 negatively regulates autophagy through the mTOR signaling pathway in ovarian cancer cells
Ye, W., Han, T., Wang, R., Wei, J., Peng, K., Lin, Q., & Shao, G. (2018) · Oncology Reports · doi:10.3892/or.2018.6432 · Cited by 28
Cancer synthetic vulnerabilities to protein arginine methyltransferase inhibitors
Guccione, E., Schwarz, M. C., Tullio, F. D., & Mzoughi, S. (2021) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2021.04.004 · Cited by 28
Zhou, W., Yun, Z., Wang, T., Li, C., & Zhang, J. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.07.106 · Cited by 27
Yang, G., Liu, Y., Ding, L., Tao, F., Zhu, M., Shi, Z.-Y., Wen, J.-M., Niu, M.-Y., Xiang, L., Xu, Z.-S., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.989575 · Cited by 27
Wang, X., Oishi, N., Shimakami, T., Yamashita, T., Honda, M., Murakami, S., & Kaneko, S. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i18.3252 · Cited by 26
Day, C. A., Hinchcliffe, E. H., & Robinson, J. (2022) · Cells · doi:10.3390/cells11213376 · Cited by 26
Regulation of the tumor suppressor PML by sequential post-translational modifications
Schmitz, M. L., & Grishina, I. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00204 · Cited by 25
Kuang, Y., Xu, H., Lu, F., Meng, J., Yi, Y., Yang, H., Hou, H., Hao, W., & Su, S. (2020) · Cancer Science · doi:10.1111/cas.14708 · Cited by 25
Dai, Q., & Ye, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.793425 · Cited by 25
Kim, Y., Park, K., Kim, Y. J., Shin, S.-W., Kim, Y. J., Choi, C., & Noh, J. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415539 · Cited by 24
MYST2 acetyltransferase expression and Histone H4 Lysine acetylation are suppressed in AML
Sauer, T., Arteaga, M. F., Isken, F., Rohde, C., Hebestreit, K., Mikesch, J., Stelljes, M., Cui, C., Zhou, F., Göllner, S., et al. (2015) · Experimental Hematology · doi:10.1016/j.exphem.2015.05.010 · Cited by 23
Exploring the Multi-Faceted Role of Sirtuins in Glioblastoma Pathogenesis and Targeting Options
Kunadis, E., & Piperi, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112889 · Cited by 23
Cho, H. I., Kim, M. S., & Jang, Y. K. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.05.022 · Cited by 22
Time dependent modulation of tumor radiosensitivity by a pan HDAC inhibitor: abexinostat
Rivera, S., Leteur, C., Mégnin-Chanet, F., Law, F., Martins, I., Kloos, I., Depil, S., Modjtahedi, N., Perfettini, J., Hennequin, C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.14813 · Cited by 22
Peng, K., Zhuo, M., Li, M., Chen, Q., Mo, P., & Yu, C. (2021) · Oncogene · doi:10.1038/s41388-021-01678-9 · Cited by 22
Marrelli, D., Ansaloni, L., Federici, O., Asero, S. V. M. A., Carbone, L., Marano, L., Baiocchi, G. L., Vaira, M., Coccolini, F., Giorgio, A. D., et al. (2022) · Cancers · doi:10.3390/cancers14236010 · Cited by 21
Jeffery, N. N., Davidson, C., Peslak, S. A., Kingsley, P. D., Nakamura, Y., Palis, J., & Bulger, M. (2021) · Epigenetics & Chromatin · doi:10.1186/s13072-021-00408-5 · Cited by 20
Jeusset, L. M., & McManus, K. J. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.12.007 · Cited by 19
Liang, Y., Su, Y., Xu, C., Zhang, N., Liu, D., Li, G., Tong, T., & Chen, J. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-00323-w · Cited by 18
Molecular Insights into the Recognition of Acetylated Histone Modifications by the BRPF2 Bromodomain
Barman, S., Roy, A., Padhan, J., & Sudhamalla, B. (2022) · Biochemistry · doi:10.1021/acs.biochem.2c00297 · Cited by 18
López, V., Tejedor, J. R., Carella, A., García, M. G., Santamarina‐Ojeda, P., Pérez, R. F., Mangas, C., Urdinguio, R. G., Aranburu, A., de la Nava, D., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.671838 · Cited by 17
Histone H3K9 methyltransferase SETDB1 augments invadopodia formation to promote tumor metastasis
Ueshima, S., & Fang, J. (2022) · Oncogene · doi:10.1038/s41388-022-02345-3 · Cited by 17
BRD1-Mediated Acetylation Promotes Integrin αV Gene Expression Via Interaction with Sulfatide
Cai, Q., Dong, Y. W., Qi, B., Shao, X., Wang, R., Chen, Z. Y., He, B. M., & Wu, X. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0527 · Cited by 15
Gong, J., Yan, S., Yu, H., Zhang, W., & Zhang, D. (2018) · Medical Science Monitor · doi:10.12659/msm.910844 · Cited by 15
Protein Post-Translational Modification Crosstalk in Acute Myeloid Leukemia Calls for Action
Hernandez-Valladares, M., Wangen, R., Berven, F. S., & Guldbrandsen, A. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190503164004 · Cited by 15
Site-Specific Phosphorylation of Histone H1.4 Is Associated with Transcription Activation
Saha, A., Seward, C. H., Stubbs, L. J., & Mizzen, C. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228861 · Cited by 15
Hakuno, S. K., Michiels, E., Kuhlemaijer, E. B., Rooman, I., Hawinkels, L. J. A. C., & Slingerland, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063147 · Cited by 15
Zhang, T., Wang, B., Gu, B., Su, F., Xiang, L., Liu, L., Li, X., Wang, X., Gao, L., & Chen, H. (2022) · Journal of Oncology · doi:10.1155/2022/3938652 · Cited by 13
Propionylation of lysine, a new mechanism of short-chain fatty acids affecting bacterial virulence.
Tang, H., Zhan, Z., Zhang, Y., & Huang, X. (2022) · PubMed · Cited by 12
Triff, K., McLean, M. W., Konganti, K., Pang, J., Callaway, E. S., Zhou, B., Ivanov, I. V., & Chapkin, R. S. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.03.009 · Cited by 11
Liu, Y., Wang, C., Su, H., Birchler, J. A., & Han, F. (2020) · Journal of Experimental Botany · doi:10.1093/jxb/eraa506 · Cited by 11
Proteomic approaches in myeloid leukemia
Kanaujiya, J. K., Lochab, S., Pal, P., Christopeit, M., Singh, S. M., Sanyal, S., Behre, G., & Trivedi, A. K. (2011) · Electrophoresis · doi:10.1002/elps.201000428 · Cited by 9
Identification of the upstream regulators of KDM5B in gastric cancer
Zhao, L., Qi, F.-Y., Zhang, J., Pang, J., Ren, H.-M., Shen, D., Zhao, L., Qi, L., Liu, H., & Zheng, Y. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120458 · Cited by 9
Visfatin and global histone H3K9me levels in colon cancer
Abdulsalam, E. A. A., & Harithy, R. N. A. (2021) · Annals of Medicine · doi:10.1080/07853890.2021.1925737 · Cited by 8
Dl-3-N-Butylphthalide Presents Anti-Cancer Activity in Lung Cancer by Targeting PD-1/PD-L1 Signaling
Jiang, Q., Zhang, N., Li, X., Hou, W., Zhao, X., & Liu, L. (2021) · Cancer Management and Research · doi:10.2147/cmar.s333416 · Cited by 8
The role of protein acetylation in regulating mitochondrial fusion and fission
Uddin, G. M., Abbas, R., & Shutt, T. E. (2021) · Biochemical Society Transactions · doi:10.1042/bst20210798 · Cited by 8
Singh, J., Minz, R. W., Saikia, B., Nada, R., Sharma, A., Jha, S., Anand, S., Rathi, M., & D’Cruz, S. (2022) · Clinical and Experimental Medicine · doi:10.1007/s10238-022-00908-y · Cited by 8
Abouelenien, F., Miura, T., Nakashimada, Y., Elleboudy, N. S., Al-Harbi, M. S., Ali, E. F., & Shukry, M. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182211988 · Cited by 7
Duan, J., Nie, R., Xiang, Z., Chen, J., Deng, M.-H., Hu, L., Wang, F., Luo, R., Xie, D., & Cai, M. (2021) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s309451 · Cited by 6
Homeobox genes gain trimethylation of histone H3 lysine 4 in glioblastoma tissue
Luo, K., Luo, D., & Wen, H. (2016) · Bioscience Reports · doi:10.1042/bsr20160028 · Cited by 4
Cited by
Acetylation of histone H3 in cancer progression and prognosis
Miziak, P., Baran, M., Borkiewicz, L., Trombik, T., & Stepulak, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252010982 · Cited by 49
Kamrani, S., Naseramini, R., Khani, P., Razavi, Z. S., Afkhami, H., Atashzar, M. R., Nasri, F., Alavimanesh, S., Saeidi, F., & Ronaghi, H. (2025) · Cancer Cell International · doi:10.1186/s12935-025-03741-x · Cited by 27
Metadata
- Authors
- Liu, R., Wu, J., Guo, H., Yao, W., Li, S., Lu, Y., Jia, Y., Liang, X., Tang, J., & Zhang, H.
- Venue
- MedComm
- Publisher
- Wiley
- Published
- 2023-05-20
- Volume
- 4
- Issue
- 3
- Pages
- e292-e292
- ISSN
- 2688-2663 (ISSN-L)
- OpenAlex
- W4377205881
- Cited by
- 264
- References
- 389
- FWCI
- 19.65
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.